| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
25,340,000 |
| Market
Cap: |
448.77(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.85 - $19.51 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 6.6 |
| Insider 6 Months : 6.6 |
| Insider 3/6 Months : 13.6 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Pulse Biosciences is a bioelectric medicine company. The CellFX® System (CellFX) is the commercial product to harness the distinctive advantages of Co.'s proprietary Nano-Pulse Stimulation™ (NPS) technology, such as the ability to non-thermally clear cells while sparing non-cellular tissue, to treat a variety of conditions for which an optimal solution remains unfulfilled. The CellFX System is a tunable, software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. Co. has also designed an integrated cloud software infrastructure called CellFX CloudConnect™. CellFX CloudConnect also facilitates direct connectivity to the CellFX System.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
10,000 |
10,000 |
1,070,434 |
11,130,651 |
| Total Buy Value |
$85,600 |
$85,600 |
$9,771,616 |
$75,105,794 |
| Total People Bought |
1 |
1 |
4 |
4 |
| Total Buy Transactions |
1 |
1 |
17 |
21 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-04-25 |
2024-01-23 |
2023-07-25 |
2022-07-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Barrett Burke Thomas |
President and CEO |
• • – |
2024-07-19 |
4 |
OE |
$11.00 |
$11,946 |
D/D |
1,086 |
12,172 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2024-07-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
118,332 |
400,877 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2024-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,187,824 |
42,172,003 |
|
- |
|
| Zanganeh Maky |
Director |
• • – |
2024-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
60,242 |
665,153 |
|
- |
|
| Danahy Kevin Patrick |
Chief Commercial Officer |
• • – |
2024-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
650 |
36,537 |
|
- |
|
| Barrett Burke Thomas |
President and CEO |
• • – |
2024-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,086 |
11,086 |
|
- |
|
| Levinson Mitchell E. |
Chief Strategy Officer |
• • – |
2024-07-03 |
4 |
OE |
$0.00 |
$0 |
I/I |
2,207 |
8,199 |
|
- |
|
| Levinson Mitchell E. |
Chief Strategy Officer |
• • – |
2024-07-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,000 |
90,880 |
|
- |
|
| Barrett Burke Thomas |
President and CEO |
• • – |
2024-05-20 |
4 |
B |
$8.56 |
$85,600 |
D/D |
10,000 |
10,000 |
2.81 |
114% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-12 |
4 |
B |
$9.15 |
$164,691 |
D/D |
17,999 |
36,984,179 |
3.92 |
-27% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-11 |
4 |
B |
$9.36 |
$843,504 |
D/D |
90,118 |
36,966,180 |
3.92 |
-25% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-08 |
4 |
B |
$9.54 |
$1,112,898 |
D/D |
116,656 |
36,876,062 |
3.92 |
-28% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-07 |
4 |
B |
$9.19 |
$687,890 |
D/D |
74,852 |
36,759,406 |
3.92 |
-23% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-06 |
4 |
B |
$9.06 |
$750,286 |
D/D |
82,813 |
36,684,554 |
3.92 |
-18% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-06 |
4 |
OE |
$5.95 |
$59,101 |
D/D |
9,933 |
36,601,741 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2023-12-05 |
4 |
B |
$9.34 |
$616,636 |
I/I |
66,021 |
351,565 |
2.25 |
-17% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-04 |
4 |
B |
$10.38 |
$280,260 |
I/I |
27,000 |
285,544 |
2.25 |
-24% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-04 |
4 |
OE |
$10.66 |
$430,099 |
D/D |
40,347 |
36,591,808 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2023-12-01 |
4 |
B |
$9.07 |
$413,592 |
I/I |
45,600 |
258,544 |
2.25 |
-21% |
|
| Duggan Robert W |
Director |
• • • |
2023-11-30 |
4 |
B |
$9.06 |
$1,385,673 |
I/I |
152,944 |
212,944 |
2.25 |
-20% |
|
| Duggan Robert W |
Director |
• • • |
2023-11-29 |
4 |
B |
$9.21 |
$552,600 |
I/I |
60,000 |
60,000 |
2.25 |
-20% |
|
| Duggan Robert W |
Director |
• • • |
2023-11-29 |
4 |
B |
$9.44 |
$1,497,184 |
D/D |
158,600 |
36,551,461 |
3.92 |
-20% |
|
| Duggan Robert W |
Director |
• • • |
2023-11-29 |
4 |
OE |
$5.95 |
$9,919 |
D/D |
1,667 |
36,392,861 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2023-11-28 |
4 |
B |
$8.98 |
$1,117,085 |
D/D |
124,397 |
36,391,194 |
3.92 |
-14% |
|
| Duggan Robert W |
Director |
• • • |
2023-11-17 |
4 |
B |
$6.09 |
$123,470 |
D/D |
20,241 |
36,266,797 |
3.92 |
31% |
|
137 Records found
|
|
Page 1 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.63 (3.44%) 
